Kemp Dolliver
Stock Analyst at Brookline Capital
(0.68)
# 4,076
Out of 5,172 analysts
19
Total ratings
38.46%
Success rate
-12.22%
Average return
Main Sectors:
Stocks Rated by Kemp Dolliver
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LSTA Lisata Therapeutics | Downgrades: Hold | n/a | $5.01 | - | 2 | Jan 21, 2026 | |
| RNTX Rein Therapeutics | Downgrades: Hold | n/a | $1.24 | - | 2 | Jan 21, 2026 | |
| VRCA Verrica Pharmaceuticals | Upgrades: Buy | $17 | $5.45 | +211.93% | 3 | Dec 18, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $18 | $4.80 | +275.39% | 1 | Jul 21, 2025 | |
| IBIO iBio, Inc. | Initiates: Buy | $3.6 | $2.09 | +72.25% | 1 | Jul 22, 2024 | |
| DARE Daré Bioscience | Upgrades: Buy | $36 | $1.36 | +2,547.06% | 2 | May 15, 2024 | |
| OTLK Outlook Therapeutics | Upgrades: Buy | $31 | $0.35 | +8,843.32% | 1 | Jan 25, 2024 | |
| LNTH Lantheus Holdings | Initiates: Buy | $100 | $76.43 | +30.84% | 1 | Nov 30, 2023 | |
| EDSA Edesa Biotech | Maintains: Buy | $57 | $7.35 | +675.51% | 2 | Oct 12, 2023 | |
| GNLX Genelux | Initiates: Hold | $25 | $2.40 | +941.67% | 1 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $6.25 | +200.00% | 1 | Jan 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $8 | $0.93 | +758.09% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5.65 | $0.63 | +799.11% | 1 | Feb 2, 2022 |
Lisata Therapeutics
Jan 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $5.01
Upside: -
Rein Therapeutics
Jan 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $1.24
Upside: -
Verrica Pharmaceuticals
Dec 18, 2025
Upgrades: Buy
Price Target: $17
Current: $5.45
Upside: +211.93%
Radiopharm Theranostics
Jul 21, 2025
Initiates: Buy
Price Target: $18
Current: $4.80
Upside: +275.39%
iBio, Inc.
Jul 22, 2024
Initiates: Buy
Price Target: $3.6
Current: $2.09
Upside: +72.25%
Daré Bioscience
May 15, 2024
Upgrades: Buy
Price Target: $36
Current: $1.36
Upside: +2,547.06%
Outlook Therapeutics
Jan 25, 2024
Upgrades: Buy
Price Target: $31
Current: $0.35
Upside: +8,843.32%
Lantheus Holdings
Nov 30, 2023
Initiates: Buy
Price Target: $100
Current: $76.43
Upside: +30.84%
Edesa Biotech
Oct 12, 2023
Maintains: Buy
Price Target: $57
Current: $7.35
Upside: +675.51%
Genelux
May 18, 2023
Initiates: Hold
Price Target: $25
Current: $2.40
Upside: +941.67%
Jan 13, 2023
Initiates: Buy
Price Target: $19
Current: $6.25
Upside: +200.00%
Oct 21, 2022
Assumes: Buy
Price Target: $8
Current: $0.93
Upside: +758.09%
Feb 2, 2022
Initiates: Buy
Price Target: $5.65
Current: $0.63
Upside: +799.11%